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Staphylococcus aureus Reservoirs and Transmission
Routes in a Portuguese Neonatal Intensive Care Unit:
A 30-Month Surveillance Study
Teresa Conceic¸a˜o,1 Marta Aires de Sousa,2 Maria Miragaia,1 Elsa Paulino,3 Rosalina Barroso,3
Maria Joa˜o Brito,3 Teresa Sardinha,3 Luı´sa Sancho,3 Helena Carreiro,3 Germano de Sousa,3
Maria do Ce´u Machado,3 and Hermı´nia de Lencastre1,4
Although Staphylococcus aureus is a major cause of outbreaks in neonatal intensive care units (NICUs), there are
no studies on the epidemiology of S. aureus isolates responsible for infection in Portuguese NICUs. Between July
2005 and December 2007, a total of 54 methicillin susceptible S. aureus (MSSA) isolates were recovered from 16
infected infants, parents, health care workers (HCWs), and the environment in a level III NICU. Isolates were
characterized by pulsed-field gel electrophoresis (PFGE), spa typing, and multilocus sequence typing. Virulence
determinants were detected by multiplex polymerase chain reaction. Three major MSSA clones were endemic in
the NICU, representing 70% (n = 38) of the isolates: PFGE type A-ST5 (n = 17); type B-ST30 (n = 12); and type C-
ST1 (n = 9). Leukotoxins and hemolysins were present in all isolates, although none of them carried PVL. HCWs,
plastic folders protecting clinical files, and mothers’ nipples were identified as potential reservoirs and/or
vehicles of dissemination of S. aureus. Consequently, additional infection control measures were implemented in
this NICU.
Introduction
N osocomial infection rates in neonatal intensivecare units (NICUs) increased over the past decade,
reaching 25.5% in premature and very-low-birth-weight
neonates.10–12,29 This group is particularly susceptible to in-
fections due to their immature immune system, which is
reflected in the high rates of mortality and morbidity, and in
a significant increase in the length of hospital stay and as-
sociated costs.14,29,46 Staphylococcus aureus remains the sec-
ond major cause of hospital acquired infections in NICUs
being responsible for 16.7% of pneumonias and 22.2% of
surgical-site infections reported in neonates.12,24,46
In Portugal, the last survey of hospital infection rates
showed that S. aureus was responsible for 21.3% of total
hospital acquired infections, which are more common in
ICUs (33.2%) and pediatric units (9.3%).34 Moreover, this is a
country that has one of the highest rates of methicillin re-
sistant S. aureus (MRSA) in Europe (49.1%).16
Surveillance of nosocomial infections is essential to im-
prove the quality of patient care. Episodes of S. aureus in-
fection in neonates are frequently related to health care
workers (HCWs), parents, and environment coloniza-
tion.5,8,9,18,23,24,44 Preventing MRSA transmission within an
NICU has been shown to be achievable through imple-
mentation of optimal infection control strategies, namely
hand hygiene practices; prevention of central venous cathe-
ter-related bloodstream infections; judicious use of antimi-
crobials; skin care, as it is the first line of defense against
infection; and early enteral feeding with human milk.10,45
Although several studies have been focused on the mo-
lecular characterization of S. aureus isolates recovered from
different hospitals in Portugal over time,2,4 none of them
specifically analyzed the molecular epidemiology of S. aureus
in NICUs. The primary aim of the present study was to
identify the incidence, reservoirs, and routes of transmission
of S. aureus isolates responsible for infection in one of the
largest Portuguese NICUs, in order to implement additional
adequate infection control strategies in the unit and reduce
infection rates. A second aim of the study was to describe the
population structure of the S. aureus clones circulating in this
NICU.
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Materials and Methods
Setting
Hospital Fernando Fonseca is a large tertiary care hospital
(670 beds) located in the suburbs of Lisbon, Portugal, that
services an outpatient population of about 600,000, and has
the second largest maternity ward in the country with
*5,400 deliveries per year. The NICU is a level III unit with
26 beds and an admission of about 450 neonates per year, out
of which around 17% have very low birth weight (£ 1,500 g).
One hundred HCWs work in this NICU.
Study design and case definition
From July 2005 to December 2007, all neonates admitted
for at least 72 hours at the NICU and presenting clinical
symptoms of S. aureus infection, namely positive hemo-
cultures, were included in the study. Neonates were con-
sidered infected if S. aureus was isolated from a normally
sterile site (e.g., blood) or from other cultures obtained for
clinical purposes (e.g., umbilical exudates) when there was
suspicion of infection. Whenever an infected infant was
identified, an active surveillance screening was performed to
detect eventual S. aureus carriers and reservoirs: nasal swabs
from parents of the infected infant and HCWs that worked in
the NICU during the 4 days preceding each infection case;
swabs from the skin of mothers’ nipples in case of breast
feeding; and swabs from the environment of the NICU
(cardio-respiratory monitors, incubators, milk pumps,
stethoscopes, plastic folder protecting the infants clinical re-
cords hanging on the incubators, and telephones). In the case
of multiple infection cases occurring within the same 45-day
period since the detection of the first case, HCWs were
screened only once, and the infection cases were considered
as a part of the same infection episode. The infection epi-
sodes and the infected neonates were chronologically iden-
tified by roman and arabic numbers, respectively.
The Hospital Ethic Committee approved the study, and an
informed consent was obtained from each individual
screened, or from the parents in the case of infants.
Statistical analysis
Descriptive statistics such as frequency and percentage, or
mean – standard deviation were used to characterize the
population. Infection rates were calculated considering the
number of infection cases per 1,000 patient days per month
and the number of infection cases per 100 admitted neonates
(cumulative incidence rate) during the study period.
Bacterial identification
Blood samples were cultured in BD BACTEC Plus Aero-
bic/F media and incubated in BACTEC 9000 MB apparatus
(Becton and Dickinson) for a maximum of 7 days and then, if
positive, plated onto PolyViteX Chocolate agar selective
media (bioMe´rieux). Screening swabs were inoculated onto
Columbia Blood agar plates (bioMe´rieux) and incubated at
37C overnight. All S. aureus isolates were identified by co-
agulase agglutination test using the STAPH AUREUS FU-
MOUZE kit (Fumouze Diagnostics) and by production of
catalase using the ID Color Catalase kit (bioMe´rieux), fol-
lowed by a semiautomatic identification through the VITEK2
system, using Gram-positive identification cards (GP-card)
(bioMe´rieux SA). All isolates were conserved at - 80C in
tryptic soy broth with 15% of glycerol.
Antimicrobial susceptibility testing andmecA screening
Susceptibility testing to a panel of eight antibiotics (peni-
cillin, amoxicillin-clavulanic acid, flucloxacillin, ciprofloxacin,
erythromycin, tetracycline, gentamicin, and trimethoprim-
sulfamethoxazole) was performed with the semiautomatic
VITEK2 system, according to the manufacturer’s instructions.
Detection of mecA was performed on all S. aureus isolates by
polymerase chain reaction (PCR).38
Molecular typing
Pulsed-field gel electrophoresis. Pulsed-field gel electro-
phoresis (PFGE) was performed on all isolates after SmaI
digestion as described by Chung et al.13 The resulting pat-
terns were analyzed by visual inspection using the criteria of
McDougal et al.,32 followed by an automated analysis with
BioNumerics software version 4.61 (Applied Maths) for re-
latedness evaluation. Dendrograms were generated as pre-
viously described,17 except that a tolerance value of 1.3% for
band pattern comparisons was used. Dice coefficient simi-
larity cutoff at 85% and 95% were used for PFGE type and
subtype clusters definition, respectively.
spa typing and multilocus sequence typing. A represen-
tative isolate of each PFGE type, preferably recovered from
infants, was selected for further characterization by spa typ-
ing and multilocus sequence typing (MLST) as described.1,15
spa types were assigned using the Ridom web server (http://
spaserver.ridom.de).1 MLST allelic profiles, sequence types,
and clonal complexes were defined using the MLST online
database (www.mlst.net).
Detection of virulence determinants
The presence of 21 staphylococcal virulence genes,
including 3 leukocidins (lukS-lukF, lukE-lukD, and lukM), 3
hemolysins (hlb, hlg, and hlgv), and 15 super-antigenic toxins
(eta, etb, etd, sea, seb, sec, sed, see, seg, seh, sei, sej, sel, sep, and
tst) were determined by PCR in all isolates, as described.35,47
The detection of the accessory gene regulator (agr) group
(I–IV) was performed on representative isolates of each
PFGE type, as described.21
Results
Incidence of S. aureus infection in the NICU
and clinical characteristics of the infection episodes
From July 2005 through December 2007, 1,021 high-risk
infants were admitted in the NICU, of whom 16 developed
an invasive infection due to methicillin susceptible S. aureus
(MSSA), which corresponds to a rate of 0.86 infection cases
per 1,000 patient days per month (ranging from 0 to 4.84
infection cases per 1,000 patient days per month) or 1.57
infection cases per 100 admissions. No invasive MRSA in-
fections were detected in the NICU during the 30-month
study period.
Fifteen out of the 16 infected infants were delivered in the
maternity ward (Caesarean section, n= 12) and were directly
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transferred to the NICU due to prematurity (mean gesta-
tional age of 31 weeks, ranging from 24 to 39 weeks) and/or
low birth weight (mean of 1,187.5 g, and standard deviation
of 649.8 g). Male accounted for 64.3% of the infants, and
71.4% were Caucasians. All the infants had venous central
catheters and/or peripheral punctures at sepsis diagnosis,
and 11 received parenteral nutrition. The mean time to ac-
quire an S. aureus infection since admittance to the NICU was
15 days (ranging from 2 to 39 days) with the exception of
infant 6 who got infected 187 days after admission. Two
infants infected during the same episode died of multiorgan
failure.
S. aureus isolates collected in the NICU
The 16 infection cases reported were distributed over 10
infection episodes, resulting in a total of 54 S. aureus isolates:
30 isolates recovered from the 16 infants and 24 isolates re-
covered from surveillance screenings (Table 1). In four cases,
different infants were infected within the same period of 45
days and were, therefore, included in the same infection
episode (Fig. 1). The 30 S. aureus isolates from infants were
recovered from hemocultures (n= 19, 66.3%), catheters
(n = 5), umbilical exudates (n= 2), wounds (n= 1), pus of in-
testinal abscess (n = 1), pus of skin abscess (n= 1), and urine
(n = 1).
Among the 154 swabs obtained from the surveillance
screenings, 24 S. aureus isolates were recovered from 18
HCWs (n = 19, including two isolates from a re-colonized
individual), two fathers (n= 2), nipples of a mother (n= 2),
and the environment (n= 1).
A total of 64 out of the 100 HCWs working in this NICU
were screened during the study period showing a prevalence
of S. aureus nasal colonization of 28% (18 out 64). We em-
phasize that 53% of the screened HCWs (34 out of 64) were in
contact with an infected infant in different episodes and for
this reason, they were screened more than once (number of
screenings: one [n = 30 HCWs], two [n = 25], three [n = 7], four
[n = 1], and five [n = 1]).
Both mother and father of seven infants were available for
nasal screening. Only two fathers (infants 3 and 7) were nasal
carriers for MSSA. The nipples of the mother of the single
breastfed infant (infant 16) were screened, and two MSSA
isolates were recovered.
Regarding the NICU environment, different inanimate
surfaces were swabbed: cardio-respiratory monitors (n= 3),
plastic folders hanging on the incubators to protect the
clinical paper files (n = 3), incubators (n= 6), milk pumps
(n = 4), stethoscopes (n= 3), and telephones (n = 9). The un-
ique MSSA isolate recovered from the NICU environment
was isolated from a plastic folder.
Antimicrobial resistance
A common nonmultiresistant antibiotic profile character-
ized all the isolates from this study: none was resistant to
amoxicillin-clavulanic acid, flucloxacillin, gentamicin, tetra-
cycline, and trimethoprim-sulfamethoxazole; four (from
three infants) were susceptible to penicillin; three showed
resistance to erythromycin, and one isolate (from an infant)
was resistant to ciprofloxacin; and none of the isolates car-
ried the mecA gene.
Molecular characterization and virulence factors
The molecular characterization distributed the 54 MSSA
isolates into 11 PFGE types (A to H and J to L) (Table 1). The
majority of the isolates (n = 38, 70.4%) belonged to three
major clonal types: A-ST5 (n = 17); B-ST30 (n= 12); and C-ST1
(n= 9). Representatives of each of these clonal types were
characterized by spa types t1228, t012, and t922, respectively.
Isolates belonging to PFGE types A, B, C, and H were
recovered during different episodes from infants and HCW
(Fig. 1): A (seven episodes), B (six episodes), C (four epi-
sodes), and H (two episodes), while isolates with PFGE types
K and J were identified in both infants and HCW in the same
episode. PFGE types D and E contained isolates recovered
from infants only, while types F, G, and L were exclusively
associated to HCW.
The prevalent clonal types, PFGE A-ST5 and PFGE B-ST30
were recovered during the study period, while PFGE C-ST1
appeared sporadically in 2006 during episode III and then re-
appeared in May 2007 (Fig. 1). The remaining clonal types
were recovered sporadically in isolated episodes.
Table 2 presents the virulence determinants found among
the 54 MSSA isolates. Although none of the isolates was
positive for PVL, lukM, eta, etb, etd, seb, sej, and see, all am-
plified sel. Isolates other than those belonging to PFGE types
B and J were positive for lukE-lukD and g-hemolysin variant.
PFGE types B, D, and E and the single isolate type L, har-
bored b-hemolysin. Only isolates belonging to PFGE type B
presented both b- and g-hemolysins. Genes sec, seh, and sep
were exclusively found among isolates of type C, while only
isolates of types B and F were positive for the tst gene, which
encodes the toxic shock syndrome toxin.
Concerning the auxiliary gene regulator (agr), agr type I
was associated to seven PFGE types found in this study (C-E,
G, and J-L). Isolates belonging to PFGE types B and F
showed agr type III, while isolates with PFGE types A and H
presented agr types II and IV, respectively (Table 1).
MSSA reservoirs and transmission routes
In three infection cases, the same strain was recovered
from the infant and at least one HCW (infant 1/HCW58-
episode I; infant 13/HCWs 16, 34, and 52 and infant 15/
HCW28- episode IX) (Table 1 and Fig. 1).
In episode VI, the infant was infected with the same strain
(PFGE type A3) recovered in previous episodes from a HCW
(episode II) and from the environment (plastic folder for
clinical records hanging on an infant incubator - episode IV).
In four infants (infants 2, 5, 9, and 11), the same strain was
recovered from the blood and the catheter (Table 1), sug-
gesting the catheters as the possible source of infection.
In episode X, the strain responsible for the infant’s infec-
tion was found on the mother’s nipples. In no other episode
did we find identical isolates shared by the infant and any of
the parents.
S. aureus with three distinct PFGE types were responsible
for infection in multiple infants in distinct episodes (PFGE
type A2: infants 5 and 13; PFGE type B1: infants 1 and 8;
PFGE type C3: infants 14 and 16). Moreover, strains A2 and
B1 were detected in several HCWs (Fig. 1). Interestingly,
HCW52, colonized with strain A2 in episode IX, had been
previously colonized with a different strain (PFGE F1) in
episode II. This was the only HCW that showed an
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Table 1. Molecular Characterization of the 54 MSSA Isolates Recovered During 10 Infection Episodes
in a Portuguese NICU from July 2005 to December 2007
MLST
Episode Isolate ID Isolation date Source Individual PFGE type spa typea ST CC agr type
I HFF191 Jul-05 Exudate Infant1 B1 t012 30 30 III
I HFF192 Aug-05 Catheter Infant2 A1
I HFF193 Aug-05 Blood Infant2 A1 t1228 5 5
I HFF196 Sep-05 Nasal HCW24 A2
I HFF194 Sep-05 Nasal HCW58 B1
II HFF198 Nov-05 Blood Infant3 E t377 630 8
II HFF199 Nov-05 Exudate Infant3 E
II HFF190 Nov-05 Blood Infant4 E I
II HFF203 Nov-05 Nasal Father3 B2
II HFF200 Nov-05 Nasal HCW51 A3
II HFF202 Nov-05 Nasal HCW52 F t1537 707 sing III
II HFF201 Nov-05 Nasal HCW53 G t008 1508 8 I
III HFF206 Jan-06 Catheter Infant5 A2
III HFF207 Jan-06 Blood Infant5 A2
III HFF208 Jan-06 Urine Infant5 A2
III HFF226 Feb-06 Blood Infant6 D t2152 188 15 I
III HFF227 Feb-06 Blood Infant6 D
III HFF225 Jan-06 Nasal HCW15 H1
III HFF209 Jan-06 Nasal HCW55 C1 t922 1 15
IV HFF274 Apr-06 Blood Infant7 B3
IV HFF276 May-06 Nasal Father7 A4
IV HFF275 May-06 Surface Environment A3
V HFF280 Jul-06 Blood Infant8 B1
VI HFF427 Mar-07 Catheter Infant9 A3
VI HFF428 Mar-07 Blood Infant9 A3
VII HFF507 May-07 Blood Infant10 C2
VIII HFF500 Jun-07 Blood Infant11 B4
VIII HFF501 Jun-07 Catheter Infant11 B4
VIII HFF502 Jun-07 Blood Infant11 B4
VIII HFF503 Jun-07 Nasal HCW54 B5
IX HFF613 Oct-07 Catheter Infant12 K1 t091 7 7 I
IX HFF620 Oct-07 Blood Infant12 H2 t2155 121 121 IV
IX HFF614 Oct-07 Blood Infant13 A2 II
IX HFF617 Oct-07 Exudate Infant13 A2
IX HFF618 Oct-07 Blood Infant14 C3
IX HFF619 Oct-07 Exudate Infant14 C3
IX HFF621 Nov-07 Blood Infant15 J1 t065 45 45 I
IX HFF622 Nov-07 Blood Infant15 J1
IX HFF629 Nov-07 Nasal HCW34 A2
IX HFF631 Nov-07 Nasal HCW52 A2
IX HFF636 Dec-07 Nasal HCW61 A2
IX HFF627 Nov-07 Nasal HCW26 B1
IX HFF630 Nov-07 Nasal HCW48 B6
IX HFF628 Nov-07 Nasal HCW32 B7
IX HFF625 Nov-07 Nasal HCW28 J1
IX HFF635 Dec-07 Nasal HCW27 J2
IX HFF632 Nov-07 Nasal HCW4 K2
IX HFF626 Nov-07 Nasal HCW61 L t514 101 101 I
X HFF637 Dec-17 Nasal HCW56 A2
X HFF633 Dec-07 Blood Infant16 C3 I
X HFF634 Dec-07 Blood Infant16 C3
X HFF638 Dec-17 Nipple Nipple16-R C3
X HFF639 Dec-17 Nipple Nipple16-L C3
X HFF640 Dec-07 Pus Infant16 C3
aRidom nomenclature (http://spaserver.ridom.de/)
MLST, multilocus sequence typing; ST, sequence type; CC, clonal complex, defined by eBurst v3 accessed on 28 September 2011; sing,
singleton; HCW, health care worker; nipple16, mother’s nipples from infant 16; R, right; L, left;MSSA,methicillin susceptible S. aureus; NICU,
neonatal intensive care units.
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FIG. 1. Transmission routes and reservoirs of MSSA identified in the NICU from July 2005 to December 2007. Continuous
arrows indicate the same PFGE subtype between isolates. Clonal types are color differentiated. HCW, health care worker;
NICU, neonatal intensive care units; nipple16, mother’s nipples from infant 16; R, right; L, left.
Table 2. Representative Isolates of Each PFGE Subtype Found Among the MSSA Collection
and Related Virulence Determinants
Virulence determinantsa
Isolate ID Individual PFGE subtype lukE-lukD hlb hlg hlgv sea sec sed seg seh sei sep tst
HFF193 Infant2 A1 + - - + - - - + - + - -
HFF207 Infant5 A2 + - - + - - - + - + - -
HFF428 Infant9 A3 + - - + - - - + - + - -
HFF276 Father7 A5 + - - + - - - + - + - -
HFF191 Infant1 B1 - + + - - - - + - - - +
HFF203 Father3 B2 - - - - - - - + - - - +
HFF274 Infant7 B3 - + + - - - - + - - - +
HFF500 Infant11 B4 - + + - - - - + - - - +/ -
HFF503 HCW54 B5 - + + - - - - + - - - +
HFF630 HCW48 B6 - + + - + - - + - - - +
HFF628 HCW32 B7 - + + - + - - + - - - +
HFF209 HCW55 C1 + - - + + - - - + - - -
HFF507 Infant10 C2 + - - + - - - - - - - -
HFF618 Infant14 C3 + - - + - + - - - - + -
HFF226 Infant6 D + + - + - - - - - - - -
HFF198 Infant3 E + + - + - - - - - - - -
HFF202 HCW52 F + - - + - - + - - - - +
HFF201 HCW53 G + - - + - - + - - - - -
HFF225 HCW15 H1 + - - + - - - + - - - -
HFF620 Infant12 H2 + - - + - - - + - - - -
HFF621 Infant15 J1 - - + - - - - +/ - - + - -
HFF635 HCW27 J2 - - + - - - - + - + - -
HFF613 Infant12 K1 + - - + - - - - - - - -
HFF632 HCW4 K2 + - - + - - - - - - - -
HFF626 HCW61 L + + - + - - - - - - - -
aAll isolates were tested for 21 virulence genes. Only virulence determinants that showed variance in presence/absence are listed. The
totality of the isolates were positive for sel encoding staphylococcal enterotoxin L and negative for lukF-lukS-PV and lukM encoding the
Panton Valentine leukocidin and leukocidin M, respectively; eta, etb, and etd, encoding exfoliative toxins A, B, and D and seb, see, and sej,
encoding staphylococcal enterotoxins B, E, and J. lukE-lukD—leukocidins D and E genes; hlb, hlg, and hlgv—b-hemolysin, g-hemolysin, and g-
hemolysin variant genes, respectively; sea, sec, sed, seg, seh, sei, sel, and sep—staphylococcal enterotoxins A, C, D, G, H, I, L, and P genes,
respectively; tst—toxic shock syndrome toxin gene.
HCW, health care worker; + , gene presence; - , gene absence; +/ - , variable result within the same PFGE subtype.
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intermittent carriage of two clonally distinct strains, sug-
gesting the occurrence of re-colonization.
Discussion
S. aureus infections in NICUs are a matter of great concern,
as the newborn population is particularly vulnerable. In the
present study, we assessed the epidemiology of S. aureus
infections in a level III Portuguese NICU during a 30-month
period. During this time, no MRSA infections occurred;
however, 16 infants were infected with MSSA, correspond-
ing to a rate of 0.86 infection cases per 1,000 patient-days per
month or 1.57 infection cases per 100 total admissions. These
values are considerably lower than the estimated values in a
large NICU in the United States or in Brazil (2.18 and 4.4
MSSA infection cases per 100 admissions, respectively).11,44
Molecular typing showed that three predominant MSSA
clonal types A (ST5), B (ST30), and C (ST1), were responsible
for infection in 11 out of the 16 infants, and were maintained
in the unit during the whole study period (30 months),
suggesting that these clones were not only endemic but had
high epidemicity as well. The pathogenic potential of these
clonal types is apparent in a study by Grundmann et al.
where these clonal types were common among the most
frequent MSSA responsible for invasive disease in Europe.26
Moreover, ST5 and ST30 strains were found to be the most
common among nosocomial MSSA isolates from Portugal
recovered between 1992 and 2003, suggesting that they
should be endemic in many Portuguese hospitals.3 Interest-
ingly, the ST5 genetic background appears to be also com-
mon among the MRSA population, not only in the hospital
where this study was undertaken—where the New York/
Japan MRSA clone (ST5-SCCmec II) was the major MRSA
clone in adult wards in 2006—but also disseminated among
all Portuguese hospitals, being the second most preva-
lent clone in the country, following the EMRSA-15 clone
(ST22-IVh).2
It is well known that HCWs who are nasal carriers play an
important role as sources of S. aureus transmission, and
neonatal outbreaks due to HCWs colonizing strains have
been previously reported.8,27,33,42 In the present study, most
HCWs were colonized with MSSA clonal types that were
endemic in the unit and, therefore, may be acting as reser-
voirs of potential pathogenic MSSA strains inside the NICU.
CA-MRSA outbreaks have been also described in NICUs due
to vertical transmission from colonized parents.37,43 In the
present study, in a single episode, the strain responsible for
sepsis and abscess infection in the infant (PFGE C3-ST1) also
colonized the mother’s nipples. Although nowadays ex-
pressed breast milk should be pasteurized before use, pre-
vious studies have shown vertical transmission of MRSA
through contaminated breast milk.7,19 In our study, the
mother was not nasally colonized, which prevents us from
suggesting that the direction of the transmission was from
the mother to the child. Since clone C was endemic in the
NICU and S. aureus nasal colonization frequently occurs
soon after birth,25,28 the infant might have been first colo-
nized, developing the infection later from an endogenous
source and subsequently colonized the mother’s nipples that
became a reservoir for the infection strain. Evaluation of the
nasal carriage among the infants could have provided in-
sights on the possible endogenous transmission.
HCWs and infants’ parents may constitute a bridge be-
tween the hospital and the community, and represent pos-
sible vehicles for the introduction of community-related
isolates in the NICU.
NICU environmental surfaces are potential growing set-
tings for nosocomial pathogens, and numerous fomites have
been reported as reservoirs for nosocomial transmission.14,18
Moreover, it is known that S. aureus can be stable in dry
environments with a median survival time of 12 days (1 to
> 60 days) on inanimate surfaces in ICUs.20,30 In the present
study, a single MSSA isolate recovered from one plastic
folder showed a PFGE indistinguishable from the strains
colonizing a HCW and infecting an infant several months
apart. The fact that the plastic folders hanging on each in-
cubator were not replaced between consecutive infants could
act as an S. aureus reservoir in this NICU and, therefore,
increased the risk of cross-transmission.
The majority (13 out of 16) of the infants were infected
with isolates belonging to clonal types endemic in the NICU
(clonal types A, B, and C) and/or colonizing HCWs (clonal
types J and K). However, three infants were infected by
unique clones, nonrelated to any other MSSA isolate recov-
ered during the study period, and the source of these isolates
could not be determined. Transient contamination of HCWs
hands has been documented on many occasions6,22,40 and
could have been the way through which S. aureus was
transmitted to patients. Nevertheless, it was not possible to
evaluate it retrospectively.
Nosocomial MSSA isolates are usually susceptible to most
antimicrobial agents, and their success is probably due to
their increased virulence, rather than multiresistance.36 The
MSSA isolates circulating in the NICU, in fact, showed a
common nonmultiresistant profile, but carried several viru-
lence factors including leukocidins, hemolysins, and super
antigens. The MSSA isolates that simultaneously infected
infants 3 and 4 (PFGE type E isolates), who died after in-
testinal lesions and consequently multiorgan failure, pro-
duced several different toxins (hemolysins, one leukocidin,
and one enterotoxin), which could have been responsible for
necrosis of the intestinal host cells, as reported for the
pathogenesis of enterocolitis due to S. aureus.31
After episode II (November 2005), when two infected ba-
bies died and the unit was closed for disinfection, several
infection control measures have been implemented in the
unit: (1) After each episode, all medical material that was in
contact with an infected infant, including incubators, was
carefully disinfected (tablets containing 50% of sodium di-
chloroisocyanurate followed by ethanol); (2) Implementation
of a routine replacement of the plastic folder hanging on the
incubators at each new admission; (3) Educational work-
shops on staphylococcal infections in NICUs were performed
in the unit for all HCW with emphasis on correct hand-
washing procedures, a key factor for the infection control.10
The study presents some limitations, especially concerning
the surveillance screening process. In the majority of the
episodes, the screening was incomplete, as some HCWs were
not available or did not agree to being screened. Therefore,
some reservoirs and/or transmission routes may have been
underestimated or even not identified. Data regarding the
noninfected infants admitted to the NICU were not available,
and risk factors for MSSA infection could not be traced.
Nevertheless, some particular traits, already reported as
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major risk factors for infection, were also present in the in-
fected infants included in this study, namely the low gesta-
tional age, the low birth weight, and the use of central
catheters and/or peripheral punctures. Since colonization
with commensal bacteria in infants admitted at an NICU
cannot be avoided, a periodical screening of all infants
would not only establish global S. aureus carriage rates, but
also identify exactly the time of colonization as well, which is
known to be a risk factor for infection.39,41
In the present study, we showed that nationally and in-
ternationally disseminated MSSA clones were endemic in a
major Portuguese NICU, and we provided evidence for the
role of HCWs as reservoirs and vehicles of transmission of
S. aureus in this high-risk setting. Plastic clinical folders that
are usually hanging on the infants’ incubators were shown
for the first time to act as a potential reservoir of S. aureus.
The study led to the improvement of infection control mea-
sures in the NICU, and may serve as a model to other NICUs
in Portugal.
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